申请人:DuPont Pharmaceuticals Company
公开号:US05886191A1
公开(公告)日:1999-03-23
The present application describes amidinoindoles, amidinoazoles, and analogs thereof of formula I: ##STR1## wherein W, W.sup.1, W.sup.2, and W.sup.3 are selected from CH and N, provided that one of W.sup.1 and W.sup.2 is C(C(.dbd.NH)NH.sub.2) and at most two of W, W.sup.1, W.sup.2, and W.sup.3 are N and one of J.sup.a and J.sup.b is substituted by --(CH.sub.2).sub.n --Z--A--B, which are useful as inhibitors of factor Xa or thrombin.
该申请描述了公式I中的氨基吲哚,氨基唑和其类似物:其中W、W.sup.1、W.sup.2和W.sup.3从CH和N中选择,前提是W.sup.1和W.sup.2中的一个是C(C(.dbd.NH)NH.sub.2),最多两个W、W.sup.1、W.sup.2和W.sup.3是N,J.sup.a和J.sup.b中的一个被--(CH.sub.2).sub.n --Z--A--B取代,这些化合物可用作因子Xa或凝血酶的抑制剂。